Shujun Xiao
State Key Laboratory Of Medical Genomics
Shanghai, 200025, China
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Mutant p53 reactivation and DNA demethylation in the treatment of AML/MDS.
Journal: Science translational medicine
Published: August 12, 2026
Heterogeneity of TP53 mutations necessitates differentiation with p53-rescue therapies.
Journal: Nature reviews. Cancer
Published: May 16, 2025
p53 mutation-associated prognosis across cancer types underlines hematological malignancy as an applicable cancer type to p53-rescue therapy.
Journal: Fundamental research
Published: December 23, 2024
RIG-I-Inducing Small Molecules Potently Inhibit HMA-Resistant AML Through Igniting the Overloaded dsRNA Arsenal.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 07, 2024
AcGlcAs: A Novel P53-Targeting Arsenical with Potent Cellular Uptake and Cancer Cell Selectivity.
Journal: Journal of medicinal chemistry
Published: December 09, 2023
Characterization of the generic mutant p53-rescue compounds in a broad range of assays.
Journal: Cancer cell
Published: July 24, 2023
Arsenic trioxide extends survival of Li-Fraumeni syndrome mimicking mouse.
Journal: Cell death & disease
Published: July 07, 2023
Pharmacological rescue of mutant p53 triggers spontaneous tumor regression via immune responses.
Journal: Cell reports. Medicine
Published: June 12, 2023
Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties.
Journal: Science translational medicine
Published: April 05, 2023
A Prognostic Model for Acute Myeloid Leukemia Based on IL-2/STAT5 Pathway-Related Genes.
Journal: Frontiers in oncology
Published: September 29, 2021
Last Updated: 09/26/2026